🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to confirm non-inferiority of the three MenACWY vaccines (Men...
Status
Completed
Location
Children's Hospital Research Institute, University of Calgary
Start Date
2018-09-20
Trial ID
NCT03694405
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The purpose of this booster vaccination study is to evaluate the persistenc...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00135564
Treatments Being Tested
In the UK, infants currently receive a 5-in-1 vaccine (Pediacel) at 2, 3 an...
Status
Completed
Location
St George's Vaccien Institute
Start Date
2013-07
Trial ID
NCT01896596
The purpose of this study in healthy toddlers who have not previously been ...
Status
Completed
Location
Werderstrasse 3
Start Date
2008-03
Trial ID
NCT00617760
The purpose of the study is to evaluate the immune response of toddlers, to...
Status
Completed
Location
Universidad Rey Juan Carlos I
Start Date
2007-01
Trial ID
NCT00392808
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
The purpose of this primary vaccination study is to evaluate the immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00135486
Treatments Being Tested
This study evaluated the safety and immunogenicity of 3 formulations of Hib...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-03-01
Trial ID
NCT00129116
Treatments Being Tested
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested